Shares of Medtronic PLC MDT slid 1.65% to $83.45 Monday, on what proved to be an all-around poor trading session for the ...

Shares of Zimmer Biomet Holdings Inc. tumbled 11.62% to $90.48 Monday, on what proved to be an all-around dismal trading ...

WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 ...

Shares of Medtronic PLC MDT rose 1.54% to $84.85 Friday, on what proved to be an all-around favorable trading session for the ...

FDA approves Medtronic adaptive deep brain stimulation system for Parkinson's Disease NORTHAMPTON, MA / ACCESS Newswire / May 6, 2025 / Liza Bobrow didn't think it was a big deal when her handwriting ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

Medical device specialist Medtronic (NYSE: MDT) has not performed well over the past five years; the stock has significantly ...

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

Paul Mead, CEO of CorFlow, said “Chris brings exceptional strategic and operational acumen to CorFlow at a pivotal growth phase, where the company can benefit tremendously from his experience. Chris ...